
DeSci Labs
@DeSciLabs
Followers
23K
Following
1K
Media
172
Statuses
890
We build infrastructure for open and transparent scientific publishing of papers, data, and code. Powered by cutting-edge Web3 & AI technology. #DeSci
Metascience coordination space
Joined August 2021
DeSci Labs does NOT currently have a token. Any token on Solana or any other blockchain is NOT affiliated with our project. We are working to take down infringing logos that have been brought to our attention, although we appreciate the enthusiasm of the trading community.
50
24
244
RT @DesciFoundation: How do you ensure essential research tools remain open, accessible, and community-governed over time?. We explored thi….
0
1
0
How is DeSci Labs transforming the world of scientific publishing?. We’ve teamed up with @pathologistmag to explore the limitations of traditional publishing and how DeSci Labs is driving innovation to overcome them. Read the full piece to see how we're helping shape a more.
3
3
123
🔬DeSci Labs Featured in @biosciencetoday . We're thrilled to be spotlighted in BioScience Today's article, "The Rapid Rise of Decentralised Science," which delves into how blockchain and open-access technologies are transforming scientific publishing. Our CEO, @PKoellinger,.
1
2
21
The current academic publishing system is holding science back. Paywalls, high publication fees, and slow peer review create barriers that slow progress and limit access to knowledge. On the @timeshighered #Campus podcast, our CEO @PKoellinger dives into how we can build a more.
4
3
416
📢 Should journal editors be responsible for stopping misinformation?. A new @scholarlykitchn article asks: is it up to editors to prevent misuse of published research?. At @DeSciLabs, we see the challenge of misinformation as something that begins earlier in the research.
3
1
254
A new AI tool discovered at the @ICR_London and @UCL can predict which men with high-risk prostate cancer will benefit most from abiraterone, a treatment that can halve the risk of death. Developed by researchers in the US, UK, and Switzerland, the tool could help doctors offer.
3
2
108